Abyrx, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
Nov 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Therapeutic putties containing additives including processed human blood plasma (US 11,672,885) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 2 fees due Jun 30, 2027
- 1 fee due Jul 7, 2027The maintenance fee for Multi-putty adhesive and cement compositions for tissue hemostasis, repair and reconstruction (US 10,525,160) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
- 1 fee due Aug 4, 2027The maintenance fee for Compositions and methods for hemostasis (US 10,549,009) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Absorbable multi-putty bone cements and hemostatic compositions and methods of use (US 9,314,547) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,989,000 | Absorbable putty-like implants and methods for their use for mechanical hemostasis of bone and for the treatment of osseous defects In force · From the USPTO record | In force | From the USPTO record | |
| US 8,105,628 | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects In force · From the USPTO record | In force | From the USPTO record | |
| US 7,955,616 | Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects In force · From the USPTO record | In force | From the USPTO record | |
| US 8,603,528 | Compositions and method for the reduction of post-operative pain In force · From the USPTO record | In force | From the USPTO record | |
| US 8,338,498 | Polymeric bone defect filler In force · From the USPTO record | In force | From the USPTO record | |
| US 8,337,497 | Methods for sternal closure In force · From the USPTO record | In force | From the USPTO record | |
| US 8,668,697 | Methods and devices for sternal closure In force · From the USPTO record | In force | From the USPTO record | |
| US 8,852,199 | Method and device for handling bone adhesives In force · From the USPTO record | In force | From the USPTO record | |
| US 9,314,547 | Absorbable multi-putty bone cements and hemostatic compositions and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,046,083 | Multi-putty adhesive and cement compositions for tissue hemostasis, repair and reconstruction In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 30: 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 3 no status recorded